STAT+: Eli Lilly and the ‘societal obligation’ of GLP-1s

Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.
Source
Stat News
Opens original article in a new tab

Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said.

(MedPage Today) -- Note that some links may require registration or subscription. Jeff Webb, 76, an entrepreneur who started a cheerleading business and also was a mentor to the late conservative activist Charlie Kirk, died from a head injury...

Merck intends to buy Terns Pharmaceuticals, the developer of a promising leukemia treatment, for $6.7 billion

In today's Morning Rounds newsletter: A federal vaccine adviser departs ACIP, adults turn to AI chatbots for health info, and radiologists sift through deepfake X-rays.